Skip to main content

Table 3 Cox regression analysis of prognostic factors influencing overall survival

From: CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling

Variables

Univariate analysis

Multivariate analysis

HR

95% CI

P

HR

95% CI

P

Age (y)

  ≤ 60

1

  

-

  

  > 60

1.114

0.663–1.870

0.684

   

Gender

 Female

1

  

-

  

 Male

1.640

0.888–3.029

0.114

   

T stage

 T1

1

  

1

  

 T2

1.731

0.716–4.186

0.223

1.703

0.703–4.128

0.239

 T3

3.571

1.416–9.009

0.007

3.609

1.410–9.235

0.007

 T4

2.616

0.925–7.398

0.070

2.937

1.030–8.373

0.044

N stage

 N0

1

  

1

  

 N1

2.103

1.049–4.218

0.036

2.371

1.172–4.798

0.016

 N3

2.060

1.173–3.616

0.012

1.831

1.020–3.287

0.043

Grade

 G1

1

  

-

  

 G2

0.903

0.374–2.179

0.820

   

 G3

1.471

0.689–3.144

0.319

   

TNM stage

 I

1

  

-

  

 II

1.212

0.567–2.590

0.620

   

 III

2.235

1.156–4.320

0.017

   

Vessel invasion

 No

1

  

-

  

 Yes

1.306

0.753–2.266

0.343

   

Adjuvant therapy

 No

1

  

-

  

 Yes

0.836

0.499–1.402

0.498

   

Expression level of circSCAP

 Low

1

  

1

  

 High

0.585

0.353–0.970

0.038

0.636

0.380–0.984

0.048

  1. HR hazard ratio, CI confidence interval